KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $57,679,000 | +73.4% | 320,779 | 0.0% | 0.02% | +69.2% |
| Q2 2017 | $33,255,000 | +15.8% | 320,779 | -12.3% | 0.01% | +8.3% |
| Q1 2017 | $28,707,000 | +70.4% | 365,745 | -2.7% | 0.01% | +71.4% |
| Q4 2016 | $16,848,000 | -16.0% | 375,745 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $20,047,000 | +24.0% | 375,745 | +16.2% | 0.01% | +12.5% |
| Q2 2016 | $16,168,000 | +16.5% | 323,365 | +7.0% | 0.01% | +14.3% |
| Q1 2016 | $13,873,000 | -30.3% | 302,169 | -6.4% | 0.01% | -30.0% |
| Q4 2015 | $19,900,000 | +33.3% | 322,946 | +20.4% | 0.01% | +25.0% |
| Q3 2015 | $14,930,000 | – | 268,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |